The U.S. government will ship more of Gilead Sciences Inc’s
(GILD.O) antiviral treatment remdesivir to states experiencing an increase in
COVID-19 cases including California, Texas, Florida and Arizona, according to
the Department of Health and Human Services’ website.
The government reallocated remdesivir to states with
increasing cases, White House task force coordinator Deborah Birx said during a
briefing on Friday.
HHS said on its website that the doses will ship starting
Monday and extinguish the full amount of Gilead’s donation of 120,647 treatment
courses. It said it would continue to work with Gilead to determine how the
company’s anticipated inventory of 2 million doses by year’s end will be
allocated.
California will receive 464 cases of 40 vials each, Texas
will receive 448 cases of 40 vials, Florida will receive 360 cases of 40 vials
and Arizona will receive 356 cases of 40 vials, according to the website.
Post a Comment
We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...